These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6533213)

  • 1. [A case of apolipoprotein E3 deficiency (E2/2 phenotype) associated with renovascular hypertension and atherosclerosis obliterans].
    Chiao S; Nozaki S; Hara H; Nakajima T; Kameda K; Kubo M; Tokunaga K; Hirobe K; Matsuzawa Y; Tarui S
    Nihon Naika Gakkai Zasshi; 1984 Dec; 73(12):1805-10. PubMed ID: 6533213
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
    Kobori S; Nakamura N; Uzawa H; Shichiri M
    Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of variant apolipoprotein E by isoelectric focusing and restriction isotyping in a patient with type III hyperlipoproteinemia.
    Nassar BA; McPherson R; Lamothe EM; al-Sultan AI; Zhang ZJ; Rosenblatt DS
    Clin Chem; 1991 Jul; 37(7):1308. PubMed ID: 1677318
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis.
    Okubo M; Aoyama Y; Harada K; Fukawa M; Tsukada T; Mokuno H; Yamada N; Murase T
    Atherosclerosis; 1998 Sep; 140(1):187-90. PubMed ID: 9733231
    [No Abstract]   [Full Text] [Related]  

  • 5. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
    Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia and accelerated atherosclerosis.
    Hazzard WR
    Hosp Pract (Off Ed); 1988 May; 23(5A):41-50. PubMed ID: 2967303
    [No Abstract]   [Full Text] [Related]  

  • 7. Relation of cardiovascular risk factors to atherosclerosis in type III hyperlipoproteinemia.
    Feussner G; Wagner A; Ziegler R
    Hum Genet; 1993 Sep; 92(2):122-6. PubMed ID: 8370576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Connections between apolipoprotein E genotypes and the development of cardiovascular diseases].
    Végh C; Langmár Z; Szerző M; Agota A; Marosi K; Szabolcs Z; Nagy ZB
    Orv Hetil; 2012 Dec; 153(52):2070-6. PubMed ID: 23261995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
    Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apolipoproteins and atherosclerosis--study of apolipoprotein E].
    Taniguchi T; Yamasaki S
    Rinsho Byori; 1984 Jul; 32(7):772-9. PubMed ID: 6389939
    [No Abstract]   [Full Text] [Related]  

  • 11. Apolipoprotein epsilon 2/3 genotype and type III hyperlipoproteinemia among Taiwanese.
    Lin HP; Kao JT
    Clin Chim Acta; 2003 Apr; 330(1-2):173-8. PubMed ID: 12636937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
    Rall SC; Weisgraber KH; Innerarity TL; Bersot TP; Mahley RW; Blum CB
    J Clin Invest; 1983 Oct; 72(4):1288-97. PubMed ID: 6313758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A5 S19W may play a role in dysbetalipoproteinemia in patients with the Apo E2/E2 genotype.
    Martín-Campos JM; Rico N; Bonet R; Mayoral C; Ordóñez-Llanos J; Blanco-Vaca F
    Clin Chem; 2006 Oct; 52(10):1974-5. PubMed ID: 16998123
    [No Abstract]   [Full Text] [Related]  

  • 14. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenotype of apolipoprotein E, hyperlipidemia and atherosclerosis].
    Davignon J; Roederer G
    Union Med Can; 1988 Feb; 117(1):56-61. PubMed ID: 3376345
    [No Abstract]   [Full Text] [Related]  

  • 16. Simple precipitation-based method for the screening of type III hyperlipoproteinemia.
    Nauck M; Glatt L; März W; Feussner G; Wieland H
    Clin Chem; 1999 Jun; 45(6 Pt 1):909-11. PubMed ID: 10352005
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.
    Havel RJ; Kotite L; Kane JP; Tun P; Bersot T
    J Clin Invest; 1983 Jul; 72(1):379-87. PubMed ID: 6860421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexisting dysbetalipoproteinemia and familial hypercholesterolemia. Clinical and laboratory observations.
    Carmena R; Roy M; Roederer G; Minnich A; Davignon J
    Atherosclerosis; 2000 Jan; 148(1):113-24. PubMed ID: 10580177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity.
    Karube M; Nakabayashi K; Fujioka Y; Yoshihara K; Yamada A; Matsunaga A; Saito T
    Clin Exp Nephrol; 2007 Jun; 11(2):174-179. PubMed ID: 17593519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
    Gregg RE; Ghiselli G; Brewer HB
    J Clin Endocrinol Metab; 1983 Nov; 57(5):969-74. PubMed ID: 6578216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.